These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20554607)

  • 1. Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration.
    Keane PA; Patel PJ; Ouyang Y; Chen FK; Ikeji F; Walsh AC; Tufail A; Sadda SR
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5431-7. PubMed ID: 20554607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.
    Joeres S; Kaplowitz K; Brubaker JW; Updike PG; Collins AT; Walsh AC; Romano PW; Sadda SR
    Ophthalmology; 2008 Feb; 115(2):347-354.e2. PubMed ID: 17628685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative subanalysis of cystoid spaces and outer nuclear layer using optical coherence tomography in age-related macular degeneration.
    Kashani AH; Keane PA; Dustin L; Walsh AC; Sadda SR
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3366-73. PubMed ID: 19168893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration.
    Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM
    Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration.
    Keane PA; Liakopoulos S; Chang KT; Wang M; Dustin L; Walsh AC; Sadda SR
    Ophthalmology; 2008 Dec; 115(12):2206-14. PubMed ID: 18930551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration.
    Keane PA; Heussen FM; Ouyang Y; Mokwa N; Walsh AC; Tufail A; Sadda SR; Patel PJ
    Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1152-61. PubMed ID: 22281826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials.
    DeCroos FC; Toth CA; Stinnett SS; Heydary CS; Burns R; Jaffe GJ;
    Ophthalmology; 2012 Dec; 119(12):2549-57. PubMed ID: 22939114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration.
    Ladewig MS; Karl SE; Hamelmann V; Helb HM; Scholl HP; Holz FG; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):17-25. PubMed ID: 17701197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials.
    Jaffe GJ; Martin DF; Toth CA; Daniel E; Maguire MG; Ying GS; Grunwald JE; Huang J;
    Ophthalmology; 2013 Sep; 120(9):1860-70. PubMed ID: 23642377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.
    Emerson MV; Lauer AK; Flaxel CJ; Wilson DJ; Francis PJ; Stout JT; Emerson GG; Schlesinger TK; Nolte SK; Klein ML
    Retina; 2007; 27(4):439-44. PubMed ID: 17420695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments.
    Aggio FB; Farah ME; Silva WC; Melo GB
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):215-20. PubMed ID: 17139490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment-naive patients.
    Pedersen KB; Sjølie AK; Møller F
    Acta Ophthalmol; 2009 Nov; 87(7):714-9. PubMed ID: 19094171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of error in optical coherence tomography central macular thickness measurement in wet age-related macular degeneration.
    Ghazi NG; Kirk T; Allam S; Yan G
    Am J Ophthalmol; 2009 Jul; 148(1):90-6.e2. PubMed ID: 19403111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration.
    Patel PJ; Chen FK; Da Cruz L; Rubin GS; Tufail A;
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3089-93. PubMed ID: 21310910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.